Drug Labelling information and advertisements: Extent of use as sources of drug information by members of the public in Lagos, Nigeria
Contenu principal de l'article
Résumé
Drug information is pertinent to promoting rational drug use, drug labels and advertisements are channels through which healthcare professionals, patients, care givers and members of the public get information necessary to make healthcare decisions. This study assessed the extent of use of drug labels and advertisements as sources of drug information by non-healthcare personnel in Lagos, South West, Nigeria. A structured questionnaire was developed and respondents were to indicate how often they obtain drug information from the items listed as possible, drug information sources based on a scale of 1-5. Descriptive statistics was reported as frequencies, percentages, means and standard deviations. Inferential analysis was done by calculation of student t-test and one-way ANOVA as appropriate. P-values less than 0.05 were interpreted as significant. The sources of information were sorted according to the five extracted components, pharmacists were the most consulted source for medicine information with the highest mean score of (3.29), the next most commonly used sources were television (3.26), radio (3.13) and the internet (3.02). Others are literature inserts (3.13) and labels (3.12). A significant difference was found between the components (P<0.05), which indicates that the extent of use is different. Females are more likely to use commercial advertisement sources (P<0.05), those with higher income are more likely to use doctors, Pharmacists, and labels on medicines (P<0.05), while those with low income and unemployed are more likely to rely on free sources such as family members, drug hawkers, and billboards. Members of the public and other non-healthcare professionals rely on the pharmacist and also rely to a very large extent on television, radio, literature inserts, drug labels, nurses and the internet as sources of drug information.
Téléchargements
Renseignements sur l'article
Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale - Pas de Modification 4.0 International.
Références
Ahn H.Y., Park J.S., and Haley E., 2014. Consumers' optimism bias and responses to risk disclosures in direct-to-consumer (DTC) prescription drug advertising: The moderating role of subjective health literacy. Journal of Consumer Affairs 48:175–194
Anyim JSK., Communication and information services, an essential part in clinical pharmacy, Journal of West African Pharmacy 1992; (6) 1-5
Aspden P, Wolcott JA, Bootman JL, Cronenwett LR, eds. Preventing Medication Errors. Institute of Medicine, The National Academies Press: Washington DC. 2006.
Effie S. Health information sources: trust and satisfaction. International Journal of Healthcare, 2016 (2)1: 38-43.
European Medicines Agency, 2009. Guidelines on the Readability of the Labelling and Package Leaflet of Medicinal Products for Human use.
Fabrican SJ. and Hirschhorn N., 1987 Deranged distribution perverse prescription, unprotected use: the irrationality of pharmaceuticals in the developing world. Health Policy 2: 204 -213.
Hernandez L.M., 2008. Standardizing medication labels: Confusing patients less: Workshop summary. Washington, DC: Institute of Medicine.
Honig P.K. and Gillespie B.K., 1995. Drug interactions between prescribed and over the counter medication drug saf 13 (2): 296-303
International Federation of Pharmaceutical Manufacturers & Associations. IFPMA, 2017.
Jadav S.S., Dumatar C.B., Dikshit R.K., 2014. Drug promotional literatures (DPLs) evaluation as per World Health Organization (WHO) criteria. J App Pharm Sci. 4 (06): 084088.
Kaptchuk T.J. and Miller F.G., 2005. What Is the Best and Most Ethical Model for the Relationship between Mainstream and Alternative Medicine: Opposition, Integration or Pluralism? Academic Medicine 80(3):286–90.
Khakhkhar T, Mehta M, Shah R, Sharma D., 2013. Evaluation of drug promotional literatures using WHO guidelines. Journal of Pharmaceutical Science. 4 (1).
Mauro M., 1990. What is information for patient? Large scale pilot study on experimental package inserts giving information on prescribed and over the counter drugs. British Medical Journal. 301 (6763)
Medlock S, Saeid E, Askari M, Derk L.A., Sent D, Rooij S.E., Ameen A.H., 2015. Health information seeking behaviour of seniors who use the internet: A survey. Journal med internet Res. 17(1) e 10.
Mohammed E.K., Chewning B.A., Ashiraf M.H., 2010. Sources of DI for patients with chronic condition in Alexandria, Egypt. International Journal of Pharmacy Practice. Do1: 10.11111) 2042-7174.2010.00069. National Agency for Food and Drug Administration and Control Decree 1993 No.15; Drug Products Labelling Regulations. Sect. 15 (2005).
Närhi U. and Helakorpi S. 2007. Sources of medicine information in Finland. Health Policy. 84(1):51-7
Norris P. 2005. Drug promotion, what we know, what we have yet to learn. Reviews of materials in WHO/HAI database on drug promotion. Available Medicine 13(4): 231-240.
Oh K.M., Krebs G.L., Jun J., 2012. Examining the health information seeking behaviors of Korean Americans. J. Health Commun. 17(7):779-801.
Omole M.K, Drug information source. Lectures delivered at mandatory continuing professional development programme organized by the PCN 1998; 4:1-7
Ositchu A. (|1989). Ocular drug abuse in Lagos Acta Ophthamol. 67: 396-400
Parli K., Reema R., Devang R. and Supriya M., 2017. Evaluation of promotional drug literature provided by medical Representatives at tertiary hospital. IJPSR vol 8 (4): 1744-1750
Spurling G.K., Mansfield P.R., Montgomery B.D., Lexchin J., Doust J., Othman N. and Vitry A.I., 2010. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: A systematic review. PLoS Medicine 7(10): 123- 156
Ulla N, 2007. Sources of medicine information and their reliability evaluated by medicine users. Pharmacy world science. 29(6) 688-694.
United States Food and Drugs Administration, 2015. Drug Labelling requirements: 21 C.F.R 201 Subparts A and C.
Ventola C.L. (2011). Direct-to-consumer pharmaceutical advertising: Therapeutic or toxic. Pharmacy and Therapeutics 36: 681–684.
Vinker S, Eliyahu V. Yaphe J., 2007. The effect of drug information leaflets on patient behaviour. Sr Med Assre J. 9(5); 383-6
Vredenburgh A.G. and Zackowitz I.B., 2008. Drug Labeling and its Impact on Patient safety. Proceedings of The Human Factors And Ergonomics Society 52nd Annual Meeting. 842-84
Weissman J.S., Blumenthal D., Silk A.J., Leitman R., Zapert K. and Newman M. (2003). Consumers' Reports on the Health Effects of Direct-to-Consumer Drug Advertising. Health Affairs 26(7):46-78
Williamson L. 2014. Patient and citizen participation in health: the need for improved ethical support. Amj biotech .14 (16): 4-16
Wolf M.S. and Parker R.M., 2007. A Health Literacy and Medication Safety Initiative. American College of Physicians Foundation.
World Health Organisation Health Promotion Glossary Geneva: WHO; 1998.
World Health Organisation, 2002. Technical Report Series, Annex 9- Guidelines on packaging for Pharmaceutical products.
Yusuff K.B., and Sanni W.A., 2011. Itinerant vending of medicines inside buses in Nigeria: vending strategies, dominant themes and medicine-related information provided. Pharmacy Practice (Internet) 9(3):128-135.